Literature DB >> 25079116

Clinical and molecular characterization of enhanced S-cone syndrome in children.

Sarah Hull1, Gavin Arno2, Panagiotis I Sergouniotis1, Peter Tiffin3, Arundhati Dev Borman1, Aman Chandra1, Anthony G Robson1, Graham E Holder1, Andrew R Webster1, Anthony T Moore1.   

Abstract

IMPORTANCE: Enhanced S-cone syndrome (ESCS) forms part of the differential diagnosis of night blindness in childhood.
OBJECTIVE: To report in detail the clinical phenotype and molecular genetic findings in a series of children with ESCS. DESIGN, SETTING AND PARTICIPANTS: Nine children with ESCS from 5 families underwent full ophthalmic examination, electrophysiological testing, and retinal imaging at a genetic eye disease clinic of a tertiary referral eye hospital. Bidirectional Sanger sequencing of all exons and intron-exon boundaries of NR2E3 was performed. MAIN OUTCOMES AND MEASURES: Results of ophthalmic examination and sequence analysis of NR2E3.
RESULTS: In total, 5 girls and 4 boys with a diagnosis of ESCS were included in the study. All patients had developed nyctalopia from early childhood. Visual acuity ranged from 0.00 to 1.20 logMAR (20/20 to 20/320 Snellen). All patients had hyperopia. Three patients had nummular pigmentary lesions along the arcades as typically seen in adults, 4 patients had mild pigmentary disturbance or white dots along the arcades, and 2 patients had a normal retinal appearance, although their fundus autofluorescence imaging demonstrated foci of increased autofluorescence along the arcades. Three patients had macular schisis-like changes on optical coherence tomography. Eight patients had electrophysiological testing at a mean age of 8.6 years (age range, 3-14 years), and in each patient the findings were consistent with the diagnosis of ESCS. Direct sequencing of NR2E3 identified 3 previously described mutations and 4 novel mutations. Seven patients were compound heterozygous for mutations in NR2E3, and 2 additional sibling patients were presumed to be homozygous for a missense change based on parental sequencing. CONCLUSIONS AND RELEVANCE: In this sample, children with ESCS had an early onset of night blindness and hyperopia but no nystagmus. Based on this study, children with ESCS may initially manifest a normal fundus appearance but later develop mottled retinal pigment epithelium change along the arcades, followed by the appearance of white dots in the same distribution. Fundus autofluorescence imaging is abnormal in children with a normal fundus appearance. The electrophysiological findings are pathognomonic and allow targeted molecular screening and a specific diagnosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25079116     DOI: 10.1001/jamaophthalmol.2014.2343

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  10 in total

1.  Two-color pupillometry in enhanced S-cone syndrome caused by NR2E3 mutations.

Authors:  Frederick T Collison; Jason C Park; Gerald A Fishman; Edwin M Stone; J Jason McAnany
Journal:  Doc Ophthalmol       Date:  2016-03-31       Impact factor: 2.379

2.  Novel clinical findings in autosomal recessive NR2E3-related retinal dystrophy.

Authors:  Vittoria Murro; Dario Pasquale Mucciolo; Andrea Sodi; Ilaria Passerini; Dario Giorgio; Gianni Virgili; Stanislao Rizzo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-10-15       Impact factor: 3.117

3.  Exome sequencing for structurally normal fetuses-yields and ethical issues.

Authors:  Hagit Daum; Tamar Harel; Talya Millo; Avital Eilat; Duha Fahham; Shiri Gershon-Naamat; Adily Basal; Chaggai Rosenbluh; Nili Yanai; Shay Porat; Doron Kabiri; Simcha Yagel; Dan V Valsky; Orly Elpeleg; Vardiella Meiner; Hagar Mor-Shaked
Journal:  Eur J Hum Genet       Date:  2022-09-07       Impact factor: 5.351

4.  New truncation mutation of the NR2E3 gene in a Japanese patient with enhanced S-cone syndrome.

Authors:  Kazuki Kuniyoshi; Takaaki Hayashi; Hiroyuki Sakuramoto; Hiroshi Mishima; Hiroshi Tsuneoka; Kazushige Tsunoda; Takeshi Iwata; Yoshikazu Shimomura
Journal:  Jpn J Ophthalmol       Date:  2016-08-13       Impact factor: 2.447

5.  Cystoid macular lesions are resistant to topical dorzolamide treatment in enhanced S-cone syndrome child.

Authors:  Mladen Bušić; Mirjana Bjeloš; Damir Bosnar; Senad Ramić; Iva Bušić
Journal:  Doc Ophthalmol       Date:  2016-01-23       Impact factor: 2.379

6.  ENHANCED S-CONE SYNDROME: VISUAL FUNCTION, CROSS-SECTIONAL IMAGING, AND CELLULAR STRUCTURE WITH ADAPTIVE OPTICS OPHTHALMOSCOPY.

Authors:  Michael J Ammar; Kurt T Scavelli; Katherine E Uyhazi; Emma C Bedoukian; Leona W Serrano; Ilaina D Edelstein; Grace Vergilio; Robert F Cooper; Jessica I W Morgan; Priyanka Kumar; Tomas S Aleman
Journal:  Retin Cases Brief Rep       Date:  2021-11-01

7.  Novel Pathogenic Sequence Variants in NR2E3 and Clinical Findings in Three Patients.

Authors:  Saoud Al-Khuzaei; Suzanne Broadgate; Stephanie Halford; Jasleen K Jolly; Morag Shanks; Penny Clouston; Susan M Downes
Journal:  Genes (Basel)       Date:  2020-10-29       Impact factor: 4.096

Review 8.  The electroretinogram in the genomics era: outer retinal disorders.

Authors:  Elisa E Cornish; Anagha Vaze; Robyn V Jamieson; John R Grigg
Journal:  Eye (Lond)       Date:  2021-07-07       Impact factor: 4.456

9.  Autosomal Recessive NRL Mutations in Patients with Enhanced S-Cone Syndrome.

Authors:  Karin W Littink; Patricia T Y Stappers; Frans C C Riemslag; Herman E Talsma; Maria M van Genderen; Frans P M Cremers; Rob W J Collin; L Ingeborgh van den Born
Journal:  Genes (Basel)       Date:  2018-01-30       Impact factor: 4.096

10.  A 5-Year-Old Case of Choroidal Neovascularization in Enhanced S-Cone Syndrome Treated with Ranibizumab.

Authors:  Federica Bertoli; Silvia Pignatto; Francesca Rizzetto; Paolo Lanzetta
Journal:  Case Rep Ophthalmol       Date:  2018-12-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.